Related Experiment Video
Updated: Jan 3, 2026

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
Published on: July 16, 2021
[Amyotrophic Lateral Sclerosis and Frontotemporal Dementia]
1Division of Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University.
Amyotrophic lateral sclerosis (ALS) frequently co-occurs with frontotemporal dementia (FTD), presenting with diverse language and behavioral symptoms. Accurate assessment is crucial for effective patient interventions.
Area of Science:
- Neuroscience
- Neurology
- Clinical Medicine
Background:
- Amyotrophic lateral sclerosis (ALS) often presents alongside frontotemporal dementia (FTD).
- Patients may display progressive non-fluent aphasia (PNFA) or semantic dementia (SD).
- Behavioral variant FTD (bvFTD) is characterized by executive dysfunction, language deficits, and behavioral changes like apathy and disinhibition.
Purpose of the Study:
- To highlight the frequent comorbidity of ALS and FTD.
- To underscore the range of cognitive and behavioral impairments observed in these conditions.
- To emphasize the need for precise evaluation for targeted interventions.
Main Methods:
- Review of clinical presentations and diagnostic criteria for ALS, FTD, PNFA, SD, and bvFTD.
- Analysis of cognitive and behavioral symptoms associated with these neurological disorders.
- Discussion of the importance of comprehensive patient assessment.
Main Results:
- ALS and FTD commonly co-occur, affecting language and behavior.
- A spectrum of cognitive and behavioral impairments exists, even in ALS patients without a formal FTD diagnosis.
- Specific deficits include executive dysfunction, verbal fluency issues, and personality changes.
Conclusions:
- Recognizing the overlap between ALS and FTD is critical for accurate diagnosis.
- Comprehensive neuropsychological and behavioral evaluations are essential for all ALS patients.
- Tailored non-pharmacological and pharmacological interventions depend on thorough assessment.
More Related Videos
13:31Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis
Published on: February 12, 2015
08:33Characterizing Histone Post-translational Modification Alterations in Yeast Neurodegenerative Proteinopathy Models
Published on: March 24, 2019
Related Concept Videos
Parkinson's Disease: Overview
Dementia
The progression of dementia is generally gradual....
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment